Pricing
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Nickolay V. Kukekov
0 people · 0 jobs
HQ
Astellas Pharma
48 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
494 followers
Bayer
420 followers
Bristol-Myers Squibb
287 followers
UCB
72 followers
NYU Langone Health
37 followers
Perrigo
West Pharmaceutical Services
11 followers
Dechra Pharmaceuticals
9 followers
View more